company background image
MBX logo

Microbix Biosystems TSX:MBX Stock Report

Last Price

CA$0.55

Market Cap

CA$78.3m

7D

11.1%

1Y

34.1%

Updated

16 Feb, 2025

Data

Company Financials +

MBX Stock Overview

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. More details

MBX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Microbix Biosystems Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Microbix Biosystems
Historical stock prices
Current Share PriceCA$0.55
52 Week HighCA$0.55
52 Week LowCA$0.29
Beta0.24
1 Month Change25.00%
3 Month Change71.88%
1 Year Change34.15%
3 Year Change-8.33%
5 Year Change155.81%
Change since IPO-8.33%

Recent News & Updates

Recent updates

Microbix Biosystems Inc. (TSE:MBX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Jan 04
Microbix Biosystems Inc. (TSE:MBX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Aug 22
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Feb 21
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 17
Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Dec 23
Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Nov 03
Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Jul 22
Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

May 17
Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Dec 27
Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Aug 08
Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

May 20
Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

Feb 06
Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Dec 28
One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Oct 14
Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 15
Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

May 17
A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

Mar 24
Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

Shareholder Returns

MBXCA BiotechsCA Market
7D11.1%0.3%-0.1%
1Y34.1%9.6%16.7%

Return vs Industry: MBX exceeded the Canadian Biotechs industry which returned 15.1% over the past year.

Return vs Market: MBX exceeded the Canadian Market which returned 16.6% over the past year.

Price Volatility

Is MBX's price volatile compared to industry and market?
MBX volatility
MBX Average Weekly Movement9.7%
Biotechs Industry Average Movement12.9%
Market Average Movement8.5%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market3.0%

Stable Share Price: MBX has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: MBX's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988n/aCameron Groomewww.microbix.com

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services.

Microbix Biosystems Inc. Fundamentals Summary

How do Microbix Biosystems's earnings and revenue compare to its market cap?
MBX fundamental statistics
Market capCA$78.28m
Earnings (TTM)CA$1.92m
Revenue (TTM)CA$23.03m

40.7x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MBX income statement (TTM)
RevenueCA$23.03m
Cost of RevenueCA$10.11m
Gross ProfitCA$12.92m
Other ExpensesCA$11.00m
EarningsCA$1.92m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.014
Gross Margin56.11%
Net Profit Margin8.34%
Debt/Equity Ratio20.0%

How did MBX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 10:02
End of Day Share Price 2025/02/14 00:00
Earnings2024/12/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Microbix Biosystems Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinBloom Burton & Co.
Neil LinsdelliA Capital Markets